We have previously shown that dual occupancy of slgM and CD40-essential receptors in T-dependent B cell responses-by antibodies held on CD32-L cells results in the rapid proliferation of resting human B lymphocytes in a cytokine-independent manner. Here we report the detailed phenotype of the blast population emerging in such cultures. By 3 days the levels of CD19 and CD20 have increased 4-and 2-fold respectively: such high level expression of these two pan-B markers is characteristic of cells of germinal centre (GC) origin. B cells co-stimulated via slgM and CD40 express low level CD23 and almost half become CD5 + ; they also acquire CD38 andimportantly-CD77, both of these being selective markers of GC B cells. Expression of slgM and IgD is down-regulated on these cells and a minor, but significant, population of lgG + cells appears. In marked contrast to GC B cells, the population proliferating in response to dual occupancy of slgM and CD40 has up-regulated and strongly expresses CD44. Morphologically, the cells are heterogeneous but there is a dominant blastic cell type with relatively scanty cytoplasm and having multiple nucleoli, both of which are characteristic of centroblasts; nevertheless, these cells remain morphologically distinct from freshly isolated GC B cells and do not show hallmark features of centrocvtes. Although there Is substantial cell death occurring by days 6-7 In these cultures, there is no morphological evidence for apoptosis. Thus, the proliferating population that emerges from the dual engagement of antigen receptor and CD40 on resting B cells appears to be bestowed with some features of GC B cells but has others which are Incompatible with that particular stage of differentiation. The possibility that it might represent (I) a blast stage that is transitional between activation In T zones and entry into the follicle or (II) a precursor population that colonizes the primary follicle prior to GC formation is discussed.
Introduction
B cell responses to T-dependent (TD) antigens are characterized by affinity maturation and the generation of memory. These unique features of an immune response are the result of events which occur in germinal centres (GC) of secondary lymphoid tissues: a GC is created from the differentiated progeny of antigen-specific B cell blasts which colonize a primary follicle following the T-dependent activation of resting B cells on interdigitating cells (IDC) located in T zones (1, 2) .
Proliferating centroblasts-which are derived, at least initially, from primary follicular B cell blasts-form the GC dark zone and are the targets for v^region-directed somatic hypermutation (3); centrocytes-their non-dividing offspring-are the subject of selection by antigen and T cells located in the GC light zone. Positively selected centrocytes go on to establish the memory pool and provide the precursors for plasma cells producing antibody of improved affinity. The majority of the population of GC B cells found in human tonsil has a characteristic phenotype of lgD"/CD5"/CD23"/CD39"/ CD38 + /CD77 + ; they are also negative for (centroblasts) or very weak expressors of (centrocytes) the homing molecule CD44 (4) .
The initial establishment of GC, their maintenance, and the subsequent generation of memory and secondary responses all appear to require interaction between CD40 on the B cell and CD40L-its counterstructure-on activated T h cells: Foy et al. (5) demonstrated that interfering with cognate B and T cell interaction by in vivo administration of a blocking mAb to CD40L prevented GC formation in TD responses; Gray et al (6) showed that blocking CD40-CD40L using a CD40-FCY1 fusion protein inhibited Ig production and the development of B cell memory in immunized mice. Patients with hyper-IgM syndrome have a functional disruption in the gene encoding CD40L which results in undetectable levels of serum IgG, IgA and IgE; knock-out mice deleted for either the CD40 or CD40L gene exhibit a similar phenotype and a profound inability to mount antibody responses to TD antigens (7) (8) (9) . These observations in in vivo models are compatible with results obtained in vitro where either mAb to CD40L or soluble CD40-lg block the capacity of T h cells to activate B cells while mAb to CD40, or CD40L itself, effectively rescue isolated GC B cells from their otherwise usual tendency to enter apoptosis (10-12).
We recently described how for small, resting human B lymphocytes, the co-ligation of CD40 and slg-by mAb held on CD32-transfected L cells-lowers the threshold of triggering through antigen receptor by two orders of magnitude (13) . Stimulation proceeds in a cytokine-independent fashion and we postulated that such dual occupancy of CD40 and slg might occur when B cells which have captured native antigen form cognate interactions with T h cells on IDC during the initial phases of a TD response. In the present study, we have explored the phenotypic outcome of such stimulation with the notion that activation through these receptors may form at least a component of the signals involved in the events leading to the GC reaction and its eventual sequelae.
Methods

Antibodies and cytokines
IL-4 was kindly donated by Immunex (Seattle, WA). AF6 and BU52 are murine lgG1 mAb reactive against human IgM and CD44, which were produced in the Department of Immunology, Birmingham University by D. L Hardie. OKT10 (CD38) was obtained from clones supplied by the ATCC (Rockville, MD). G28.5 mAb (lgG1) specific for human CD40 was genererously provided by J. A. Ledbetter (Bristol-Myers Squibb, Seattle, WA) and 38.13 mAb (rat IgM) specific for human CD77 was provided by J. Weils (Institut GustavRoussy, Villejuif, France) and conjugated to FITC by standard procedures. The following panel of FITC-and phycoerythrin (PE)-conjugated antibodies was purchased: CD19 (HD37-FITC), CD20 (B-Ly-1-FITC), CD5 (DK23-FITC), CD23 (MHM6-FITC), F(ab')2 rabbit anti-human IgD, IgM, K and X from Dako (High Wycombe, UK; and CD38 (Leu-7-PE) from BectonDickinson (Oxford UK). An optimal working dilution was determined for each antibody conjugate that gave the best resolution between positively stained cells and background staining with an isotype-matched control antibody conjugate.
Isolation of human resting and GC B cells
Resting tonsil B cells were prepared by negative selection protocols as described elsewhere (14) . Briefly, tonsil B cells were extracted by dissection and dispersal in RPMI 1640 (Gibco, Paisley, UK). Mononuclear cells were isolated by density gradient separation on Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden). T cells were depleted following two rounds of rosette depletion with AET-treated sheep red blood cells (SRBC) on ice. Rosettes were removed by centrifugation on Ficoll-Paque. B cells were then fractionated into high and low density populations by density centrifugation on a discontinuous isotonic Percoll gradient (Pharmacia Biotech, Uppsala, Sweden). High density B cells were taken as those that penetrated the 65% Percoll layer. The cell fraction which was buoyant on 60% Percoll was further purified by depletion of contaminating follicular mantle (FM) cells using SRBC coupled with CD39 mAb, AC2 and sheep polyclonal antihuman IgD (The Binding Site, Birmingham, UK).
In some experiments, resting B cells were freed of any contaminating GC cells following a round of depletion with CD38-coated SRBC (CD38-SRBC). High density B cells (5X10 7 ) were incubated with CD38 (OKTIO)-SRBC (2X10 8 ). The suspension was gently centrifuged to pellet cells without decanting the supernatant and incubated for 30 min at 4°C. The cells were gently resuspended and carefully layered on to Ficoll-Paque and rosettes separated from non-rosetting cells by density centrifugation. The cells collected from the interface of the Ficoll-Paque gradient were then stained and phenotyped by FACScan analysis, typically >75% IgM and <1% T cells.
In vitro culture of human resting B cells
Resting B cells were maintained in vitro by co-culture with mouse CD32-transfected L cells in the presence of anti-CD40, G28-5 (0.5 ng/ml) (15) . Mouse L cells transfected with the gene for CD32 (CD32-L cells) were obtained from DNAX (Research Institute of Cellular and Molecular Biology, Palo Alto, CA). CD32-L cells were cultured in CM [RPMI 1640 medium supplemented with 10% (v/v) FCS (Sera, Crawley Down, UK), 2 mM glutamine (Gibco), penicillin (100 lU/ml) and streptomycin (100 ng/ml)] which was supplemented with HAT selection medium-hypoxanthine (0.1 mM), aminopterin (0.4 nM) and thymidine (16 \iM) (Sigma, Poole, UK). The adherent CD32-L cells were washed in PBS, then harvested using 0.02% EDTA in PBS (pH 7). The CD32-L cells were then resuspended in CM and y-irradiated with a dose of 28,000 rad before addition to B cell cultures at a ratio of 1:10 (L cell:B cells). Typically resting B cells were resuspended at 5X10 5 cells/ml with irradiated CD32-L cells at 5X10 4 cells/ml in 200 \i\ of CM in round-bottom 96-well plates (Becton Dickinson Labware, Oxford, UK). Anti-n, mAb AF6 (1-100 ng/ml) was added directly to the B cell cultures, in the presence of anti-CD40, mAb G28-5 (0.5 ng/ml) or IL-4 (50 U/ml), when they were seeded. The cells were harvested after 3 days culture, stained and phenotyped by FACScan analysis. 
Phenotypic analysis
The surface antigen expression was studied by double immunofluorescence and analysed on a FACScan using Lysys software (Becton Dickinson). Gates for viable lymphocytes, which exclude CD32-L cells, were set on the basis of forward and side scatter. For direct double immunofluorescence staining, freshly isolated resting B cells were protected from the light and incubated at 4°C for 20 min with both FITC-and PE-labelled antibodies at the appropriate dilution in cold PBS/ 0.1% azide (pH 7.0) +5% FCS + 5% NGS. Cells were then washed and resuspended in 0.5% paraformaldehyde in PBS + 5% FCS + 5% NGS for FACScan analysis. Resting B cells cultured for 3 days with anti-CD40 form tight homotypic adhesions which were disrupted with 0.02% (w/v) disodium EDTA in PBS for 5 min at 4°C, prior to staining as above.
Results
Initial characterization of starting populations
Both resting and GC B cells were uniformly CD19 + and CD20 + ' but GC B cells expressed approximately five times more CD20 and three times more CD 19 than did resting B cells (Fig. 1) . Resting B cells were typically CD38", lgD + whereas GC B cells were IgD", CD38
+ . CD5 and CD23 were expressed at low levels on -33 and -50% of tonsil resting B cells respectively; as reported previously, CD5 was found on a minor population only of cells in the GC cell-enriched fraction while CD23 was absent on GC B cells (Fig. 1) .
Phenotype of population emerging following co-ligation of CD40 and slgM on resting B cells
Resting B cells cultured on CD32-L cells alone, CD32-L cells together with CD40 mAb and CD32 L-cells with CD40 mAb + anti-(i were analysed after 3 days for cell surface phenotype. In these initial studies, the AF6 mAb to IgM was used at 10 ng/ml, a concentration which was shown previously, and confirmed here (results not detailed), to drive optimal proliferation in resting B cells when presented together with CD40 mAb on CD32-L cells: the inclusion of 10 ng/ml AF6 on CD32-L cells enhances CD40-dependent stimulation of [ 3 H]thymidine incorporation in resting B cells by -5-fold (data not detailed).
Culture of resting B cells on CD32-L cells with CD40 mAb alone led to a 3-fold enhancement in the level of CD19 expression by day 3 compared with control values (Fig. 2) : this level of change was further augmented when slgM was co-ligated with CD40 resulting in a 4-fold enhanced expression of CD 19 relative to controls (Fig. 2) . By contrast, where CD40 ligation alone resulted in an approximate doubling in expression of slgD, co-ligation with slgM encouraged a return to the levels seen in control cultures (Fig. 2) ; a similar outcome was obtained for CD23, where the substantial up-regulation of expression of this molecule observed on CD40 ligation alone was drastically diminished upon joint ligation with slgM ( Fig. 2) .
CD38 was induced on 10% of cells following stimulation with CD40 mAb alone but this was further up-regulated such that 29% of cells were now expressing this marker when anti-n was also added to the culture system (Fig. 2) . Similarly the percentage of CD5 + cells generated showed a progressive increase with the two signals. As described previously (16) , resting tonsil B cell populations can display a wide discrepancy in the number of cells which are CD5 + . For the preparation shown here, the control population contained <1% CD5
+ cells: following culture with CD40 mAb, 19% of cells were now CD5
+ and the addition of anti-n increased the proportion to 30% (Fig. 2) . The phenotype of resting B cells, isolated by Percoll density gradient separation followed by a round of depletion with CD38-coated SRBC, was determined before and after 3 days of culture with CD40 mAb (0.5 ng/ml) alone or together with anti-fi (10 ng/ml). Two-colour FACScan analysis shows staining of each preparation with: CD2, CD38 and CD5 PE-conjugated mAb (vertical axis) versus CD19 mAb, F(ab')2 antibody to IgD and CD23 mAb conjugated to FITC (horizontal axis) respectively; or CD77 and CD44 mAb conjugated to FITC (vertical axis) versus forward scatter (horizontal axis) Fluorescence analysis was performed on total lymphocyte gate based on forward and 90° scatter. The horizontal and vertical lines are set at the threshold for positive and negative FITC or PE staining and compared with an irrelevant isotype-matched fluorescent conjugate Fluorescence intensities are shown on a log scale Importantly, on co-ligation of CD40 and slgM, 55% of cells became CD77 + ; only 25% of cells gained a very weak expression of this GC B cell-specific marker when the CD40 signal was delivered without ligating slgM: it is evident from Fig. 2 that it is the particularly large cells (high forward scatter) that are the most strongly CD77 + on B cells which have been co-cultured with CD40 mAb and anti-(U, These large cells also gain high level expression of CD44 (Fig. 2) , a marker which is characteristically low, or absent, from GC B cells.
The observed loss of slgD, the increase in CD38 expression and the concomitant induction of CD77 following stimulation with anti-n and anti-CD40, suggested that signals delivered through both the antigen receptor and CD40 may drive B cell differentiation to a GC B cell phenotype. However, the continued and increased expression of CD44 and the relatively low levels of CD38 and CD77 on these B blasts indicated incomplete differentiation to the GC cell stage. Since these results did not exclude the possibility that increased concentrations of anti-ji or indeed signals delivered through the antigen receptor alone may be sufficient to complete GC B cell differentiation, the effect of increasing concentrations of anti-n-alone or in concert with CD40-was examined together with a more extensive panel of discriminatory markers being used for analysis. In these experiments, resting B cells were cultured on CD32-L cells with increasing concentrations of anti-n (1-100ng/ml) for 3 or 7 days, either alone or in the presence of CD40 mAb. The results for expression of the different markers are displayed as histograms and the percentages of cells positive, or brightly positive, and the mean linear fluorescence (MLF) values of these populations are tabulated. All analyses are representative of six different experiments.
Co-ligation of CD40 and slgM induces high level expression of CD19 and CD20
While all resting B cells were CD19 + , it is clear from Fig. 3 (top panel) that there was a bimodal distribution in the intensity of expression of this pan-B marker. Following culture with increasing concentrations of anti-n, which by themselves deliver a weak mitogenic signal to resting B cells (13) , there was only a very modest augmentation in the level of CD19 expression and no change in the percentages of cells deemed CD19 bnght ( F ig 3 ) CD40 ijgation by itself up-regulated CD19 expression and increased the number of cells considered CD19 bn 9 ht from 42 to 58%; these 0019^^' B cells increased to 74% of the population in a dose-dependent manner upon the addition of increasing concentrations of anti-ji (Fig. 3) .
CD20 was expressed by 73% of unstimulated resting B cells and this increased to 83% on the addition of increasing concentrations of anti-n. Ligation of CD40 by itself induced the appearance of 85% CD20 briflht cells while the addition of anti-n further increased the proportion of CD20 brlGht cells in culture to 95% (Fig. 3) . These CD20 + B cells expressed twice as much CD20 on their surface as untreated B cells and approached the levels detected on freshly isolated GC B cells (Fig. 1) .
Co-ligation of CD40 and slgM reduces the level of IgD, IgM, K and X, and induces the appearance of IgG* B cells
Culture of resting B cells with anti-^ alone led to a modest reduction in the level of expression of both K and X light chains (Fig. 3) . While CD40 ligation by itself had little effect on overall surface light chain expression, co-ligation of slgM and CD40 resulted in a more substantial fall in K and X expression than seen with anti-ji alone (Fig. 3) .
The addition of increasing concentrations of anti-n reduced the percentage of lgD + B cells from 53 to 35% (Fig. 4) . Following stimulation via CD40 alone, 58% of B cells were now induced to express double the amount of IgD on their cell surface than did control cultured cells. While co-ligation of slgM and CD40 was seen to increase the percentage of B cells expressing IgD to 72%, the level of IgD on the surface of these cells was reduced virtually 2-to 3-fold over controls (Fig-4) .
Following culture with increasing concentrations of anti-n alone, the percentage of lgM + B cells remained unchanged, but the level of IgM expressed on the cell surface increased slightly. This observation is felt to be particularly important for the interpretation of these data in that it makes it unlikely that any of the observed changes in slg expression are due to simple 'antigenic modulation' by the bivalent anti-n: the failure of antibody AF6 to down-regulate its own receptor is probably a reflection of the low concentrations of mAb used and also, possibly, it being held on the CD32-L cells. Ligating CD40 alone diminished the percentage of lgM + cells from 53 to 42%; while CD40 mAb and anti-n together increased the percentage of lgM + cells in culture, as was seen for slgD, these positive cells now expressed almost 2-fold lower levels of slgM than the control population (Fig. 4) .
As documented previously (1), whereas almost half of tonsil GC B cells express slgG, only a small minority of resting B cells display this isotype. It can be seen from Fig. 4 that, for the example shown, 13% of control cultured cells were slgG + and that this number remained unchanged on ligating slgM alone. CD40 ligation, by contrast, resulted in a significant upregulation in the proportion of slgG + cells such that one-third were now positive (Fig. 4) . The further addition of anti-n had no influence on this CD40-generated change.
The induction of CD23 and CD5 by CD40 is reciprocally regulated by anti-n
CD40 signals, particularly when delivered by multimeric CD40L or cross-linked CD40 mAb, effectively induce CD23 expression on the B cell surface (17) . In the present study, resting B cells which had been cultured for 3 days either alone or with increasing amounts of anti-u. essentially expressed no CD23 (Fig. 5 ). When cultured with CD40 mAb held on CD32-L cells, 38% of resting B cells became CD23 br ' 9ht . The addition of increasing concentrations of anti-ji reduced the percentage of CD40-induced CD23 + cells from 38 to 16%, and the intensity of expression, in a clear dose-dependent manner (Fig. 5) . It was shown that this reduction was not due to increased shedding of CD23 as assessed by analysing supernatants for soluble CD23 using ELISA (results not detailed).
For the example shown in Fig. 5 , CD5 was seen to be expressed at low level by 36% of control-cultured resting B cells and this number essentially remained unchanged upon the addition of either anti-ji or CD40 mAb alone. Co-ligation of CD40 and anti-n, however, induced the appearance of 56% CD5 + cells (Fig. 5 ): this increase, albeit small, contrasts sharply to the fall in the CD40 induced level of CD23 observed upon the addition of anti-n.
Synergy between anti-fi and anti-CD40 in promoting hyperexpression of CD44
Co-ligation of CD40 and slgM resulted in a 3-fold increase in the level of CD44 expressed by 86% of B cells after culture for 3 days (Fig. 5) . While each signal alone led to some enhancement of CD44 expression, these changes were small in comparison to their combined effect Thus, while dual signalling via CD40 and slgM appear to be required for generating the majority of phenotypic changes that are indicative of differentiation toward a GC B cell, the continued and 820 CD40/BCR-generated B cell blasts increased expression of CD44 achieved is wholly inconsistent with this view.
Phenotype of resting B cells after 7 days co-ligation of CD40 and slgM
The continued co-ligation of CD40 and slgM for 7 days lowers the percentage of CD19 bri 9 tll and CD20 bri 9 w B cells observed at day 3 to levels approaching those detected on freshly isolated resting B cells (Table 1) . Although these B cells express modestly increased levels of CD 19, the levels of CD20 were reduced in a dose-dependent manner on the addition of anti-n ( Table 1) .
The percentage of lgD + B cells fell by 30% and level of IgD expressed fell 2-to 3-fold after 7 days culture in a dose-dependent manner on the addition of anti-n, in the presence of CD40 mAb (Table 1) . However, CD38, which had been induced on 31% of these IgD 10 " B cells was downregulated following the continued stimulation via CD40 and slgM. Similarly, CD23 was modesUy increased in the presence of CD40 mAb on day 3, but was reduced to control levels in the presence of anti-^ both on day 3 and day 7. The increased percentage of CD5 + B cells, observed on day 3 following coligation of CD40 and slgM, was reversed after 7 days' culture. These results suggest that the inducible GC phenotype observed after 3 days is a transient phenotype, presumably additional signals are required to maintain this GC-like population.
Comparison of the phenotype induced with CD40 atone, with anti-fi or IL-4
Ligation of slgM and IL-4 synergizes with CD40 to enhance B cell proliferation; although many features of the emergent proliferating B cells are shared, some features are quite distinct. For example, signals delivered through slgM and IL-4 synergize with signals delivered via CD40 to induce a CD40/BCR-generated B cell blasts 823 Resting B cells were incubated with CD40 mAb (500 ng/ml) alone or with IL-4 (50 U/ml) or anti-n (10 ng/ml) or with IL-4 + anti-ji for 3 days in the presence of irradiated L cells. Cultured cells were stained with FITC-conjugated CD19 mAb, CD23 mAb, (Fab') 2 IgD and PEconjugated CD5 mAb. The controls, threshold values and results are again as for Fig. 3 . Fl, fluorescence intensity.
1.2-and 1.5-fold increase in the expression of CD19 on resting B cells respectively (Table 2) , whereas the combination of IL-4 and anti-u. has no effect on the level of CD 19 relative to the phenotype induced with CD40 mAb alone. The combination of IL-4 and anti-CD40 or anti-u. and anti-CD40 lowered the level of IgD expressed by CD40 stimulated B cells by 1.6-and 2-fold and the percentage of lgD + by 9 and 23% respectively, whereas IL-4 and anti-u. induced a 2-fold increase in the level of IgD expressed, relative to the levels found on CD40 mAb stimulated B cells (Table 2 ). CD23 and CD5 were reciprocally regulated by anti-u. and IL-4: anti-n lowered the CD40 induced level of CD23 1.75-fold whereas IL-4 increased the percentage of CD40 mAb induced CD23 + B cells by 20% and elevated CD23 expression 7-fold (Table 2 ), but the combination of IL-4 and anti-u. induced a 9-fold increase in the level of CD23. These results suggest that IL-4 synergizes with CD40 to induce CD23 expression, whereas anti-u. inhibits CD40-induced CD23 expression. Figure 6(a and b) shows the typical morphology of resting and GC B cell-enriched fractions respectively. Resting B cells cultured on CD32-L cells without addition of mAb begin to look unhealthy after 3 days (Fig. 6c) but in the presence of CD40 mAb (Fig. 6d) remain fully viable and adopt a much enlarged appearance over controls. There is also now some resemblance to the GC B cell population in that these enlarged cells tend to display scanty cytoplasm and a proportion develop a somewhat cleaved nucleus, although not as pronounced as found in freshly isolated centrocytes. Those B cells incubated with CD40 and IL-4 also enlarge, but more closely resemble (lymphoblastoid) extrafollicular B cells and remain viable in culture for up to 7 days. In 3 day cultures where there has been dual ligation of CD40 and slgM ( (e) together with CD40 mAb and anti-n (10 ng/ml); and (f) after 6 days with anti-CD40 and i 6e), the majority blast population of large healthy cells fails to reveal any centrocyte tendency and has a somewhat more extensive cytoplasm; however, many cells do now have multiple, prominent nucleoli-this is a characteristic of centroblasts. The same cultures maintained for 6 days (Fig. 6f) begin to look less healthy and this is accompanied by a cessation in DNA synthesis and increased cell death (data not detailed); importantly, despite loss in viability, there is no morphological sign of apoptosis in these cultures.
Morphology of emergent B blasts following co-ligation of CD40 and slgM or IL-4 and CD40
Discussion
This study was designed in order to characterize the population of rapidly proliferating B cells which emerges on CD40/BCR-generated B cell blasts 825 stimulating high-density tonsillar B cells through slgM and CD40. The summary of the results demonstrate that this rapidly-cycling blast population: is strongly CD19 + /CD2O + ; has down-regulated slgM and IgD by -50% and a percentage of cells is now beginning to express slgG; expresses modest levels of CD23; is starting to express CD5, CD38 and CD77; and has high level expression of CD44. Some of these features are compatible with, if not characteristic of, tonsil B cells of GC origin-others, as shown in the schematic (Fig. 7) , are not. Thus, as we will discuss in detail, the findings overall are indicative of a partial shift towards cells of a GC B cell phenotype on the dual stimulation of B cell receptor and CD40 but by no means a complete driving to this stage of B cell differentiation.
Strong expression of CD38 is seen on GC B cells and plasma cells but not on recirculating or FM B cells; within the B lineage, CD77 expression is specific to GC B cells and tends to be expressed more strongly by centroblasts than centrocytes (4, 18, 19, 20, 21) . The appearance of both of these markers on the CD40/slgM-stimulated population is thus indicative of differentiation towards GC B cells. This also holds true for the increased expression in the pan-B markers CD 19 and CD20, both of which are expressed more strongly on GC compared with FM B cells in tonsils (22, 23) . Importantty, these changes and particularly the acquisition of CD77 and the up-regulation of CD38 are not simply a general feature of increased cell size. There is no change in levels of control staining and, moreover, some surface antigens show a diminished expression. Loss of slgD is an early event as cells are recruited into the GC response and the stimulated population was clearly slgD 10 " as well as slgM 10 *; the appearance of a few slgG + cells is consistent with this being the major slg isotype of GC B cells in the tonsil (1) . It should be noted that despite a diminution of slgM and IgD, no slg" cells were generated in culture. This is in keeping with observations on human tonsil GC B cells where centroblasts maintain reasonable levels of slg prior to the appearance of Ig isotype-switched centrocytes (our own unpublished data). Thus no slg" population would be anticipated even if full differentiation to a GC population was engendered. Although there was an increase in the number of cells expressing CD23, and GC B cells are typically associated with a loss of this marker, the majority of the generated blasts remained CD23~: indeed, the dual ligation of CD40 and slgM led to a substantial reduction in the amount of CD23 when compared with that expressed in response to CD40-stimulation alone. The expression of CD5-which can be seen among FM B cells-has not classically been associated with a GC B cell phenotype (24) . A rare CD5 + subset of B cells with a GC phenotype was, however, recently identified in human tonsils (16) while several groups have now described the induction of CD5 as a relatively general marker of B cell activation in man. B cells can be induced to express CD5 on their surface following stimulation with phorbol myristate acetate (PMA) and anti-lg (25) , T cells and activated T cell supernatants (26) , and anti-lg in the EL-4 culture system (27) . The discovery of CD40L on EL-4 T cells suggests that CD40 and slg ligation may have a role to play in the induction of CD5 (28) . Our results are the first to demonstrate directly the induction of CD5 with signals delivered jointly via CD40 and slg. Coligation of slg synergizes with CD40 to enhance CD40-induced CD5 expression, but-as mentioned above-lowers the level of induced CD23. The reciprocal regulation of CD23 and CD5 agrees with our observations that IL-4 induces high level expression of CD23 but no CD5 and earlier reports in which IL-4 up-regulates CD23 but down-regulates CD5 (29) (30) (31) .
Two features of the cells emerging from co-stimulation via CD40 and slg cannot be reconciled with the view that a population of GC B cells is being generated with these signals. The increase in CD44 expression is completely contrary to the diminution in the expression of this homing receptor which is associated with the GC reaction; thus, centroblasts were recently shown to be negative for CD44 while centrocytes are extremely weak expressors compared with FM B cells (4) . The continued expression of CD44 by the B cell blasts induced following the dual ligation of CD40 and slg has been described in a report by Galibert and colleagues (32,) which appeared at the conclusion of our study; however, they did not note the dramatic up-regulation of the molecule which we observed in our study. It is worth noting that the work of GaJibert era/., while reaching essentially the same conclusions as us, focused more on the conditions under which the phenotype was achieved than the detailed analysis of the phenotype per se. Thus to emphasize, unique to our study is the examination of CD19, CD20, CD23, CD5, CD77, IgM, IgG and IgD, and, importantly in our opinion, morphology. The second counter to a true GC B cell population being created is the morphology of the cells. While the population emerging was evidently heterogeneous there was, nonetheless, a dominant blast cell which was highly basophilic, showed scanty cytoplasm and had a regularly shaped nucleus. There was little evidence for the tell-tale morphology of either centroblasts or centrocytes: the former identified by being a blast cell having near-undetectable cytoplasm, the latter displaying a hallmark, prominent nuclear cleft. It is of interest, however, that the cells emerging in these cultures tended to have multiple nucleoli, a feature which is characteristic of centroblasts.
There are several possible reasons why a complete GC B cell phenotype might not be arising under the conditions of stimulation employed in this study. One is that for resting B cells to differentiate fully towards GC cells, more time is required. The data detailed here relate to 3 days of stimulation. However, it should be emphasized that when cells were analysed on day 6 or 7, there was no indication of a more developed GC B cell phenotype in these cultures: thus, cells stimulated via CD40 and slgM for 6 or 7 days showed a maintenance in CD19 expression, and a diminution in CD38, CD20, IgD, CD23 and CD5 compared with 3 day cultures. Furthermore, there was no morphologic evidence favouring a further move to a GC population in extended cultures either by the development of overt centroblasts and/or centrocytes or the appearance of apoptotic figures: the latter is of particular note given the high rate of cell death that was ensuing by days 6-7 as noted by us (data not detailed) and by Galibert et al. (32) . It is worth mentioning that even at these later times, there were no cells of a plasmacytoid appearance in these cultures which was in agreement with the failure to detect any production, above control values, of secreted Ig of all isotypes measured (own unpublished observations). Thus, simple extension of these culture conditions per se does not further develop a GC cell phenotype over and above what is seen at day 3.
A second, and potentially quite likely possibility, is that signals additional to those delivered through CD40 and slg are required for a fully-developed GC B cell. These might be needed and encountered physiologically concomitant with the primary activation on IDC by antigen and T h cells or met once a primed B cell has entered the follicle, the latter environment possibly providing signals from follicular dendritic cells (FDC) and other GC constituents. Recent evidence suggests that B7/BB1 (CD80) or B70/B7.2 (CD86) which can be induced on the B cell surface, following ligation of CD40 (33) (34) (35) , slgM (36) or MHC class II (37), or by IL-2 (38), interact with either CD28, on T cells and dendritic cells, or CTLA-4 which is inducible on activated T cells (39) . Studies in transgenic mice which lack CD28 or secrete mCTLA-4-Hy1, a murine CTLA-4 human Fc IgG 1 construct, both interfere with T cell-mediated B cell help and correlate with a lack of GC formation, poor affinity maturation and class switching (40) (41) (42) . However in CD28-deficient mice neither CTLA-4-lg or anti-B7 antibodies had a direct effect on B cell proliferation or function, suggesting that CD28 may induce additional T cell effector molecules essential for T cell mediated B cell help, such as CD40L (43) . Therefore it becomes imperative that the role played by CD80 and CD86 on B cell differentiation be investigated in the CD40 system.
A third explanation for the incomplete differentiation to a GC B cell phenotype may be the chronicity of the signal delivered to resting B cells during the 3 day culture period which is unlikely to be physiological. It has been shown that CD40L expression can be induced on the surface of T cells rapidly following TCR ligation (44) , although for stable CD40L expression, additional co-stimulation through CD28/CTLA-4 is required (37) . Since CD40 can deliver a potent direct signal to the B cell it is imperative that bystander B cell activation is prevented. The rapid up-regulation of CD40L on T cells is accompanied by a similarly rapid loss from the cell surface both spontaneously (44) and-in an accelerated fashionupon engagement of CD40 where CD40L is rapidly endocytosed from the T cell surface (45) . These studies suggest that CD40-CD40L interaction will probably be transient and that the persistent ligation of CD40 for 3 days, as occurs in our system, is unlikely to be met in vivo. Continuous stimulation through CD40-a potent survival signal-as given in our study could well explain the failure to develop-in culture-cells with a tendency to undergo apoptosis: a prerequisite to a fully-fledged GC B cell phenotype would be a downregulation of the bcl-2 'survival' gene which is likely to be precluded by ongoing CD40 stimulation. It might be argued that the continuous high rate of proliferation after co-ligation of CD40 and slg could be expected to militate against the development of centrocytes, GC cells which-unlike centreblasts-are out-of-cycle. The consequence of delivering in vitro a more transitory CD40 signal-and, possibly, a less chronic slg-dependent signal-will require further evaluation but is currently outside the scope of the present study.
Clearly it will be of interest to examine the influence of adding cytokines and/or ligating other cell surface structures in the presence of CD40 and anti-slg. The T^-product IL-4 does not appear to be a likely candidate for promoting a GC cell phenotype as its addition not only inhibits proliferation in the co-culture system but generates a population which is CD23
Wflh . However, IL-2, which is secreted by T cells following ligation of CD28 (46) , can expand lgM + , CD5 + blasts isolated from a GC fraction (16) , which display some of the features of the B cells induced following CD40 and slgM co-ligation. Also the cytokines IL-6 and IL-10, which can be induced following CD40 and slg ligation may have an important role to play in regulating B cell differentiation (47) : both are present in tonsil follicles (48) . Clearly a more detailed survey of cytokine effects is warranted in future study.
Accepting the limitations of a reductionist in vitro culture system as described here, it is none the less of interest to speculate on a possible physiologic candidate for the phenotype generated by co-ligating CD40 and slg on resting B cells. Importantly, the changes engendered through these signals are unquestionably dramatic. Moreover, the capacity to induce even a partial GC B cell phenotype is of considerable interest given that previously there was no real indication as to the signals involved in this process.
We would like to suggest as one potential physiological counterpart to the cells generated on CD40-slg co-crosslinking, the primary follicular B cell blast. This population might be expected to be intermediate between a resting, naive B cell and a differentiated GC B cell. The morphology of the population obtained would be in keeping with this as would the possession of some, but not all, phenotypic attributes of the GC B cell. As argued above, CD5-positivity may be compatible with a cell recently activated in the T zone; this marker might then be lost on further differentiation to a GC B cell. The high level expression of CD44 could also conceivably be reflecting the primary follicular B blast stage of development. This molecule has diverse functions in extracellular matrix binding, cell migration and lymphocyte homing. Its up-regulation might prelude its migration to the FDC network of the follicle: a subsequent loss may then be appropriate to the GC reaction. Among freshly isolated populations, the cell which appears most to resemble the one generated under the tissue culture conditions described here is the IgD", CD38 + , IL-2-hyper-responsive B blast present at low numbers in 'GC cell preparations' from human tonsils. While the variable presence of this population was interpreted to represent a minor subset existing in an established GC, it is possible that it arises from more recently colonized follicles within a tonsil that is dominated by the more frequent fully developed GC. A second candidate is an earlier blast cell that is transitional between initial activation in T zones and entry into the follicle, and thus could be anticipated to display the apparently schizophrenic phenotype described here. The exploration of these possibilities and of the additional requirements for developing a fully fledged GC B cell phenotype will continue to be of considerable interest given the central importance of this population in generating the features of class-switching, affinity maturation, and memory which characterize the B cell response to TD antigens.
